According to Marksans Pharma 's latest financial reports the company's total assets are $0.27 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $0.26 B | 23.35% |
2022-03-31 | $0.21 B | 29.28% |
2021-03-31 | $0.16 B | 39.75% |
2020-03-31 | $0.11 B | 3.42% |
2019-03-31 | $0.11 B | 2.93% |
2018-03-31 | $0.11 B | -3.08% |
2017-03-31 | $0.11 B | 6.96% |
2016-03-31 | $0.10 B | 0.38% |
2015-03-31 | $0.10 B | 31.96% |
2014-03-31 | $81.9 M | 10.79% |
2013-03-31 | $73.92 M | -2.34% |
2012-03-31 | $75.69 M | -31.35% |
2011-03-31 | $0.11 B | -23.48% |
2010-03-31 | $0.14 B | 16.23% |
2009-03-31 | $0.12 B | -10.29% |
2008-03-31 | $0.13 B | 21.68% |
2007-03-31 | $0.11 B | 8.32% |
2006-03-31 | $0.10 B | 94.6% |
2005-03-31 | $53.88 M |